Gregory Mattingly, MD: What FDA’s Approval of Esketamine as Monotherapy Means for Treatment-Resistant Depression
Significant Overlap Identified Between Eczema, Topical Steroid Withdrawal Symptoms
Clinical Data at IgAN Diagnosis Insufficient to Predict Long-Term Risk, Study Finds
Non-Urgent ED Utilization High For People With PsA, AS in Rural Areas